Close

Context Therapeutics (CNTX) Nominates CTIM-76 Bispecific Antibody Candidate to Develop Treatment for Claudin 6-Positive Solid Tumors

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. TSM
3. ISRG
4. SPY
5. INFY
6. SNV
7. TSLA
8. SMCI
9. SLB
10. PPG


Go back to Context Therapeutics (CNTX) Nominates CTIM-76 Bispecific Antibody Candidate to Develop Treatment for Claudin 6-Positive Solid Tumors
(NASDAQ: CNTX) Delayed: 1.32 -0.09 (6.38%)
Previous Close $1.41    52 Week High $ 
Open $1.38    52 Week Low $ 
Day High $1.45    P/E N/A 
Day Low $1.32    EPS $ 
Volume 5,702